CRVS icon

Corvus Pharma (CRVS)

NASDAQ

$17.31

-$0.98 (

-5.33%

)

1D
5D
1M
6M
1Y
5Y
Market open

CRVS: $17.31 / ₿ 0.0003 BTC / 25081 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$18.28
$2.54 - $26.95
$1.45B
0.86
$17.70
$194,550.47
83.77M
$17.26 - $17.37
$17.11 - $17.97
Yes

What is Corvus Pharma (CRVS)?

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

The Corvus Pharma (CRVS) stock price has been falling

The Corvus Pharmaceuticals, Inc. Common Stock (CRVS) stock price today is $17.31, reflecting a -5.33% move since the market opened. The company’s market capitalization stands at $1.45B, with a daily trading volume of $194.55K shares. For investors tracking price trends, Corvus Pharmaceuticals, Inc. Common Stock stock has ranged between $17.11 and $17.97 today. The previous closing price was $18.28.

Get started with Corvus Pharma (CRVS)

Ready to get started? Follow the steps below, or read our guide on how to buy Corvus Pharma stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy CRVS

Search for CRVS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy CRVS.

CRVS FAQs

CRVS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

CRVS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Corvus Pharmaceuticals, Inc. Common Stock (CRVS) has traded between a low of $2.54 and a high of $26.95.

CRVS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Corvus Pharma? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
CRVS icon
CRVS

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Corvus Pharma in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

OTRKQ icon

OTRKQ

PPBT icon
ZCMD icon

ZCMD

SVUHF icon

Top losers

Compare the worst-performing stocks of 
the day

CGBSF icon
YOTAR icon

YOTAR

OUSTZ icon

OUSTZ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.